Insight Total Assets from 2010 to 2026

IMDX Stock

5.73 1.68 22.67%

Insight Molecular Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets are likely to outpace its year average in 2026. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2014-12-31

Previous Quarter

50.5 M

Current Value

43.9 M

Quarterly Volatility

51.8 M

Yuan Drop

Covid

Interest Hikes

Check Insight Molecular financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Insight Molecular's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.4 M, Selling General Administrative of 11.5 M or Other Operating Expenses of 76 M, as well as many indicators such as Price To Sales Ratio of 18.07, Dividend Yield of 0.0015 or Days Sales Outstanding of 239. Insight financial statements analysis is a perfect complement when working with Insight Molecular Valuation or Volatility modules.

Build AI portfolio with Insight Stock

Check out the analysis of Insight Molecular Correlation against competitors.

The evolution of Total Assets for Insight Molecular Diagnostics provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Insight Molecular compares to historical norms and industry peers.

Latest Insight Molecular's Total Assets Growth Pattern

Below is the plot of the Total Assets of Insight Molecular Diagnostics over the last few years. Total assets refers to the total amount of Insight Molecular assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Insight Molecular books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Insight Molecular's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Insight Molecular's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 35.08 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Insight Total Assets Regression Statistics

	Arithmetic Mean	37,642,528
	Geometric Mean	22,495,440
	Coefficient Of Variation	110.59
	Mean Deviation	29,991,563
	Median	14,447,000
	Standard Deviation	41,628,617
	Sample Variance	1732.9T
	Range	153.2M
	R-Value	0.58
	Mean Square Error	1217.6T
	R-Squared	0.34
	Significance	0.01
	Slope	4,816,127
	Total Sum of Squares	27727.1T

Insight Total Assets History

	2026	48.3 M
	2025	40.3 M
	2024	35.1 M
	2023	74.9 M
	2022	100.1 M
	2021	159.6 M
	2020	55.4 M

Other Fundumenentals of Insight Molecular

Intangibles To Total Assets

Insight Molecular Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Short Term Investments	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Current Deferred Revenue	Net Receivables	Net Invested Capital	Short Long Term Debt	Capital Stock	Net Working Capital
Total Assets		0.76	-0.77	-0.58	0.52	-0.51	0.91	0.88	-0.25	0.92	0.62	0.52	0.63	-0.22	-0.07	0.21	-0.28
Total Stockholder Equity	0.76		-0.69	0.01	-0.11	-0.18	0.48	0.73	-0.1	0.64	0.02	0.21	0.08	0.42	0.42	-0.41	0.33
Net Debt	-0.77	-0.69		0.38	-0.38	0.57	-0.65	-0.95	0.57	-0.69	-0.42	-0.58	-0.48	0.06	-0.03	-0.06	0.09
Retained Earnings	-0.58	0.01	0.38		-0.9	0.78	-0.78	-0.45	0.45	-0.66	-0.98	-0.71	-0.84	0.9	0.5	-0.86	0.92
Accounts Payable	0.52	-0.11	-0.38	-0.9		-0.64	0.73	0.5	-0.36	0.49	0.93	0.61	0.87	-0.89	-0.7	0.86	-0.82
Short Term Investments	-0.51	-0.18	0.57	0.78	-0.64		-0.57	-0.53	0.56	-0.56	-0.78	-0.93	-0.55	0.57	0.33	-0.55	0.59
Total Liab	0.91	0.48	-0.65	-0.78	0.73	-0.57		0.76	-0.28	0.88	0.78	0.55	0.82	-0.51	-0.17	0.53	-0.55
Total Current Assets	0.88	0.73	-0.95	-0.45	0.5	-0.53	0.76		-0.38	0.75	0.51	0.55	0.6	-0.13	-0.09	0.12	-0.13
Short Term Debt	-0.25	-0.1	0.57	0.45	-0.36	0.56	-0.28	-0.38		-0.34	-0.44	-0.58	-0.34	0.36	0.14	-0.36	0.4
Intangible Assets	0.92	0.64	-0.69	-0.66	0.49	-0.56	0.88	0.75	-0.34		0.67	0.53	0.63	-0.33	-0.07	0.3	-0.45
Common Stock	0.62	0.02	-0.42	-0.98	0.93	-0.78	0.78	0.51	-0.44	0.67		0.73	0.85	-0.88	-0.61	0.85	-0.89
Current Deferred Revenue	0.52	0.21	-0.58	-0.71	0.61	-0.93	0.55	0.55	-0.58	0.53	0.73		0.52	-0.5	-0.35	0.49	-0.51
Net Receivables	0.63	0.08	-0.48	-0.84	0.87	-0.55	0.82	0.6	-0.34	0.63	0.85	0.52		-0.75	-0.43	0.76	-0.7
Net Invested Capital	-0.22	0.42	0.06	0.9	-0.89	0.57	-0.51	-0.13	0.36	-0.33	-0.88	-0.5	-0.75		0.67	-0.96	0.97
Short Long Term Debt	-0.07	0.42	-0.03	0.5	-0.7	0.33	-0.17	-0.09	0.14	-0.07	-0.61	-0.35	-0.43	0.67		-0.62	0.59
Capital Stock	0.21	-0.41	-0.06	-0.86	0.86	-0.55	0.53	0.12	-0.36	0.3	0.85	0.49	0.76	-0.96	-0.62		-0.93
Net Working Capital	-0.28	0.33	0.09	0.92	-0.82	0.59	-0.55	-0.13	0.4	-0.45	-0.89	-0.51	-0.7	0.97	0.59	-0.93

Click cells to compare fundamentals

About Insight Molecular Financial Statements

Insight Molecular investors use historical fundamental indicators, such as Insight Molecular's Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Insight Molecular. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Total Assets	40.3 M	48.3 M
Intangibles To Total Assets	0.37	0.27

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

FSLY	Fastly Class A
MOB	Mobilicom Limited American
CMG	Chipotle Mexican Grill

Additional Tools for Insight Stock Analysis

When running Insight Molecular's price analysis, check to measure Insight Molecular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insight Molecular is operating at the current time. Most of Insight Molecular's value examination focuses on studying past and present price action to predict the probability of Insight Molecular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insight Molecular's price. Additionally, you may evaluate how the addition of Insight Molecular to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC